View Author

Hill, R.L.R.

( R.L.R. Hill)


mupirocin cannulae patient cannula control infection colonization insertion site catheter group aureus insertion staphylococcus culture segment casewell cannula tips journal methicillin-resistant staphylococcus aureus staphylococci organism emrsa lumen hospital venou 15 cfu in-situ application mupirocin group carriage coagulase-negative staphylococci trial table ointment cannula tip study antibiotic in-situ time broth coagulase-negative effect society venous cannulae strain blood control group antimicrobial mupirocin-treated patients staphylococcus aureus jugular proportion reduction sepsis method intracutaneou j hosp los angeles venous catheters hospital infection society skin preparation control groups concentration iodine surgery american society mupirocin-treated in-vitro result course jugular cannulae blood agar 0.001 chemotherapy number antibiotic ointment table i tincture enrichment cannula insertion site charcoal




3 Most Recent Publications

Reduction in the colonization of central venous cannulae by mupirocin (Article)
Hill, R.L.R. Casewell, M. W.
1991-09-01
Minimal dose requirements for nasal mupirocin and its role in the control of epidemic MRSA (Article)
Casewell, M. W. Hill, R.L.R.
1991-01-01
Mupirocin for the reduction of colonization of internal jugular cannulae: a randomized controlled trial (Article)
Hill, R.L.R. Fisher, A. P. Ware, R. J. Wilson, S. Casewell, M. W.
1990-01-01